A method for focusing an X-ray method is provided and the method includes: emitting an electron beam by an electron beam generator; shooting the electron beam onto a target to generate an X-ray beam; and causing the X-ray beam to pass through each collimating channel of a same collimating channel group of a collimator to focus on a focus of the collimating channel group. The collimator includes at least one collimating channel group. Each collimating channel group includes at least two collimating channels. The same collimating channel group has one focus or a plurality of focuses.

A method that produces high energy charged particles that may be used to destroy cancer cells contained in cancerous tissues. The device uses electronic neutron generators to produce neutrons with energies that have a high probability to interact with a therapeutic source comprised of a reactive material with an outer layer of a material having a high atomic number such as Platinum or Gold. The reaction produces high energy electrons, and in some cases other charged particles with relatively short half-lives, which can destroy the cancerous cells, without seriously damaging the surrounding healthy tissue.

An example computer-implemented method for tuning a beam spot in a radiation therapy system has been disclosed. The example method includes configuring an electron beam to generate a first beam spot on an electron-beam target of the radiation therapy system, generating, using an imager of the radiation therapy system, a first plurality of projection images of the first beam spot, wherein each of the projection images of the first beam spot is generated with a line of sight blocked between the imager and a different respective portion of the beam spot, based on the first plurality of projection images, determining a value for one or more beam spot quality metrics associated with the first beam spot, and based on the value, determining whether the first beam spot is outside a specified quality range.

The disclosure pertains to a strontium-90 sealed radiological or radioactive source, such as may be used with treatment of the eye or other medical or industrial processes. The sealed radiological source includes a radiological insert within an encapsulation. The encapsulation may include increased shielding in the center thereof.

Disclosed herein is a radiotherapy device comprising a source of therapeutic radiation and an imaging system, the imaging system comprising a source of imaging radiation and a detector. The imaging system is switchable between a first configuration and a second configuration wherein, in the first configuration, the imaging system is configured to emit a beam of imaging radiation shaped for a first imaging modality toward the detector and, in the second configuration, the imaging system is configured to emit a beam of imaging radiation shaped for a second imaging modality toward the detector. The detector is of a shape formed by at least a first and a second section, the first and second section intersecting one another, wherein the first section is positioned for receiving the beam of imaging radiation for the first imaging modality, and the second section is positioned for receiving the beam of imaging radiation for the second imaging modality.

A method of monitoring a radiation dose includes impinging an electrode with radiation and measuring a current through the electrode. Emission of secondary electrons emitted from the electrode provides a majority of the current.

Disclosed herein are methods of treating a patient in need of therapy for prostate cancer comprising delivering a β-radiation-emitting composition into the prostatic vasculature. In some embodiments, an absorbed dose of 60 Gy to 200 Gy is delivered to the prostate. In some embodiments, the β-radiation-emitting composition is delivered into the arterial vasculature of the prostate via a catheter. In some embodiments, the β-radiation-emitting composition comprises a suspension of the β-radiation-emitting particles in an aqueous liquid.

Methods, systems, and compositions for maintaining functioning drainage blebs to reduce intraocular pressure (IOP) of an eye being treated for glaucoma. The methods, systems, and compositions feature the combination of a minimally invasive micro sclerostomy (MIMS) procedure and the application of beta radiation to a target area. The beta radiation can function to inhibit or reduce the inflammation and/or fibrogenesis that typically occurs after a MIMS procedure and leads to hole and/or bleb failure. By reducing inflammation and/or fibrogenesis, the MIMS holes and/or blebs can remain functioning appropriately.

A system for treating a diseased site in a human or animal body. The system includes a pharmaceutical carrier including one or more phosphors which are capable of emitting light into the diseased site upon interaction, a photoactivatable drug for intercalating into DNA of cells at the diseased site, one or more devices which infuse the diseased sited with the photoactivatable drug and the pharmaceutical carrier, an x-ray or high energy electron source, and a processor programmed to control a dose of x-rays or electrons to the diseased site for production of light inside the tumor to activate the photoactivatable drug.

A radiotherapy system includes an X-ray target configured to convert an incident electron beam into a therapeutic X-ray beam, a purging magnet configured to redirect unwanted particles emitted from the X-ray target away from the therapeutic X-ray beam, and a particle collector configured to absorb the unwanted particles subsequent to redirection by the purging magnet. The particle collector may be configured to dissipate at least 50% of the energy of the incident electron beam.